avelumab
merck,pfizer
['bladder 100', 'avelumab', 'javelin,bladder', 'biomarker', 'urothelial', 'javelin,100', 'javelin,bladder,100', 'urothelial carcinoma', 'bladder']
esmo 2022: genomic biomarkers in peripheral blood from patients enrolled in the javelin bladder 100 trial of avelumab first-line maintenance in advanced urothelial carcinoma - mashupmd 
Business & Finance News Business & Finance News News Political News US & World News Medicine & Surgery.